These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10763986)

  • 1. Hematological monitoring in patients receiving aminosalicylates.
    Yarze JC; Chase MP; Fritz HP; Herlihy KJ
    Am J Gastroenterol; 2000 Apr; 95(4):1106. PubMed ID: 10763986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Colitis therapy becomes more acceptable for patients. Rectal foam instead of enema].
    MMW Fortschr Med; 2003 Nov; 145(47):61. PubMed ID: 14725040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesalamine-associated thrombocytopenia.
    Farrell RJ; Peppercorn MA; Fine SN; Michetti P
    Am J Gastroenterol; 1999 Aug; 94(8):2304-6. PubMed ID: 10445572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ulcerative colitis. When is standard therapy enough?].
    Stange EF
    MMW Fortschr Med; 2000 Oct; 142(41):39-40. PubMed ID: 11085075
    [No Abstract]   [Full Text] [Related]  

  • 7. Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.
    Shah JA; Edwards CM; Probert CS
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):169-73. PubMed ID: 18301295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Galenic aspects and therapy of chronic inflammatory bowel diseases. Introduction].
    Schölmerich J
    Med Klin (Munich); 1999 Feb; 94 Suppl 1():3. PubMed ID: 10194939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines of DGVS. Remission. German Society of Digestive and Metabolic Diseases].
    Kruis W;
    Z Gastroenterol; 2001 Jan; 39(1):47-9. PubMed ID: 11215365
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesalazine. Now authorised for children, but no suitable form.
    Prescrire Int; 2011 Sep; 20(119):208. PubMed ID: 21954515
    [No Abstract]   [Full Text] [Related]  

  • 11. [Newcomer in ulcerative colitis: beclomethasone dipropionate: a corticoid with aim: colonic mucosa and colitis].
    MMW Fortschr Med; 2004 Jun; 146(23):63. PubMed ID: 15373139
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesalamine delivery systems: do they really make much difference?
    Qureshi AI; Cohen RD
    Adv Drug Deliv Rev; 2005 Jan; 57(2):281-302. PubMed ID: 15555743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
    Metge CJ; Blanchard JF; Peterson S; Bernstein CN
    Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patients prefer foam].
    MMW Fortschr Med; 2007 May; 149(21):48. PubMed ID: 17668735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
    Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H
    Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
    Cohen HD; Das KM
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse effect free therapy for inflammatory bowel diseases. Oral steroid with topical effect].
    MMW Fortschr Med; 2003 Sep; 145(38):61. PubMed ID: 14603689
    [No Abstract]   [Full Text] [Related]  

  • 19. [Locally acting corticosteroids in inflammatory bowel disease. Are they effective? Are they really less toxic?].
    Nos Mateu P
    Gastroenterol Hepatol; 2008 Sep; 31 Suppl 3():16-21. PubMed ID: 19087859
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
    Ryan BM; Russel MG; Langholz E; Stockbrugger RW
    Am J Gastroenterol; 2003 Aug; 98(8):1682-7. PubMed ID: 12907319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.